Stocks to watch today, December 11: Track 10 key stocks including IndiGo, LIC, Cipla, and TCS for major news and…
Track TCS, Sun Pharma, and sector leaders as Nifty eyes higher targets; spot key stocks for your Monday investment moves…
Edtech company UpGrad has submitted bids to acquire Byju’s parent company, Think & Learn,
Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…
Discover key stock movers as top Indian firms report earnings, acquisitions, and fundraises—track major business updates now!
Markets today at open, October 31: Nifty and Sensex trade flat as NTPC, Cipla slide; track top gainers and market…
ITC, Dabur, Hyundai, Cipla, Adani Power, Swiggy, and leading banks reported mixed Q2 FY26 results, reflecting varied growth across FMCG,…
Cipla reported a 3.73% year-on-year increase in net profit to Rs 1,351.17 crore for Q2FY26
Cipla shares drop 3.7% after Eli Lilly deal, but analysts see strong growth in India’s obesity market—learn more about the…
Sensex slips nearly 100 points; Nifty steady below 25,900. Track top movers and key earnings reports today!
Stay updated on stocks to watch as key defence, pharma, and manufacturing firms announce major deals and approvals—read the latest…
India has about 101 million people living with diabetes and nearly half of these in the adult patients category are…
Eli Lilly has signed a licensing deal with Cipla to market its blockbuster weight-loss drug under the brand name Yurpeak…
Muhurat Trading 2025 on BSE and NSE: Markets close Muhurat session in green as small and midcaps gain
Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…
Track Nifty as Trump’s tariff threats shake its recovery, pharma rallies, and metals falter – see how markets may move…
Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…